Sell K9 Can-C Cataract eye drops (Original) (Ready Stock) best price

Expiry: 08/23 Normalise Cataract impairment, without surgery Can-C™ K9 eye drops are the original N-acetylcarnosine eye drop formula developed to normalise senile cataract impairment for specially for dogs. In addition to senile cataract impairment, Can-C™ K9 also have other benefits. Although the information is not yet published, Russian researchers believe “that the unique Can-C™ K9 formula with its added and synergistic lubricants, could also have benefit in the following eye disorders. Users and scientists have reported that Can-C™ K9 is also great for: Dry eye syndrome. Benefit for those who wear contact lenses, particularly soft contact lenses. (Not only do the lubricants in Can-C™ help contact lenses more comfortable, but N-acetylcarnosine is also believed to inhibit the build up of lactic acid in the eye, meaning you can wear them in comfort for longer.) Corneal disorders, Computer vision syndrome, Eye strain, Ocular inflammation, Blurred vision, Presbyopia, Retinal diseases, Vitreous opacities and lesions, Complications of diabetes mellitus and other systemic diseases. Open-angle primary glaucoma. Cataract surgery is the most commonly performed operation in the world with over 1.5 operations in the USA alone every year. Although generally safe there is still a complication rate of 30 to 50% of patients who develop opacification of the posterior lens capsule within two years and require further laser treatment. Can-C™ cataract eye drops have helped thousands of people normalise their cataracts without surgery, leaving the natural lens in place rather than an artificial one. Research shows how Can-C™ K9 Drops work to normalise cataract impairment Can-C™ K9 contains a special analogue of the di-peptide carnosine, a naturally occurring nutrient that combines two amino acids or protein fragments. This particular form is known as N-acetylcarnosine or NAC and is the main ingredient due to its potency at ‘mopping up’ free radicals, the root cause of tissue damage, accelerated aging in the body and cataracts. Cataracts are caused by the process of cross linking or glycosylation, as we age our natural anti-oxidant defense against glycosylation declines, leading to the eye lens to harden and discolour over the course of a lifetime. Other forms of carnosine are broken down by naturally occurring enzymes in the eye, but the researchers found that the N-acetylcarnosine form is highly resilient and conveys the L-carnosine directly to the aqueous humor. Once in the fluid it provides the lens proteins with complete anti-oxidant protection against oxidation caused by free radicals. Human trials on people suffering from senile cataract, using a twice daily dose of Can-C™ K9 for six months showed the following remarkable results: 88.9% of patients had improved glare sensitivity.90% reported improved visual acuity – clearer and sharper vision Perhaps most significantly, 41 per cent of patients experienced a significant improvement in lens ‘transmissivity’.